vs
Side-by-side financial comparison of AGIOS PHARMACEUTICALS, INC. (AGIO) and Community West Bancshares (CWBC). Click either name above to swap in a different company.
Community West Bancshares is the larger business by last-quarter revenue ($38.3M vs $20.0M, roughly 1.9× AGIOS PHARMACEUTICALS, INC.). On growth, AGIOS PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (86.1% vs 11.6%). Community West Bancshares produced more free cash flow last quarter ($43.6M vs $-97.3M). Over the past eight quarters, AGIOS PHARMACEUTICALS, INC.'s revenue compounded faster (56.1% CAGR vs 36.0%).
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
Community West BancsharesCWBCEarnings & Financial Report
Community West Bancshares is a registered bank holding company headquartered in California. It wholly owns Community West Bank under the Bank Holding Company Act.
AGIO vs CWBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.0M | $38.3M |
| Net Profit | $-108.0M | — |
| Gross Margin | 90.6% | — |
| Operating Margin | -608.9% | 40.0% |
| Net Margin | -541.1% | — |
| Revenue YoY | 86.1% | 11.6% |
| Net Profit YoY | -11.9% | — |
| EPS (diluted) | $-1.86 | $0.58 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.0M | $38.3M | ||
| Q3 25 | $12.9M | $37.9M | ||
| Q2 25 | $12.5M | $35.7M | ||
| Q1 25 | $8.7M | $34.8M | ||
| Q4 24 | $10.7M | $34.3M | ||
| Q3 24 | $9.0M | $31.3M | ||
| Q2 24 | $8.6M | $30.5M | ||
| Q1 24 | $8.2M | $20.7M |
| Q4 25 | $-108.0M | — | ||
| Q3 25 | $-103.4M | $10.9M | ||
| Q2 25 | $-112.0M | $7.8M | ||
| Q1 25 | $-89.3M | $8.3M | ||
| Q4 24 | $-96.5M | — | ||
| Q3 24 | $947.9M | $3.4M | ||
| Q2 24 | $-96.1M | $-6.3M | ||
| Q1 24 | $-81.5M | $3.7M |
| Q4 25 | 90.6% | — | ||
| Q3 25 | 87.0% | — | ||
| Q2 25 | 86.3% | — | ||
| Q1 25 | 87.6% | — | ||
| Q4 24 | 88.3% | — | ||
| Q3 24 | 91.3% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 92.3% | — |
| Q4 25 | -608.9% | 40.0% | ||
| Q3 25 | -907.4% | 39.8% | ||
| Q2 25 | -1020.1% | 30.2% | ||
| Q1 25 | -1222.0% | 32.7% | ||
| Q4 24 | -1165.3% | 31.0% | ||
| Q3 24 | -1146.9% | 13.3% | ||
| Q2 24 | -1228.3% | -25.9% | ||
| Q1 24 | -1124.3% | 23.2% |
| Q4 25 | -541.1% | — | ||
| Q3 25 | -803.1% | 28.7% | ||
| Q2 25 | -899.4% | 22.0% | ||
| Q1 25 | -1023.3% | 23.8% | ||
| Q4 24 | -899.6% | — | ||
| Q3 24 | 10574.7% | 10.8% | ||
| Q2 24 | -1115.7% | -20.7% | ||
| Q1 24 | -995.8% | 17.8% |
| Q4 25 | $-1.86 | $0.58 | ||
| Q3 25 | $-1.78 | $0.57 | ||
| Q2 25 | $-1.93 | $0.41 | ||
| Q1 25 | $-1.55 | $0.44 | ||
| Q4 24 | $-1.44 | $0.29 | ||
| Q3 24 | $16.22 | $0.18 | ||
| Q2 24 | $-1.69 | $-0.33 | ||
| Q1 24 | $-1.45 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.1M | $119.0M |
| Total DebtLower is stronger | — | $69.5M |
| Stockholders' EquityBook value | $1.2B | $409.6M |
| Total Assets | $1.3B | $3.7B |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.1M | $119.0M | ||
| Q3 25 | $92.7M | $121.6M | ||
| Q2 25 | $80.9M | $134.4M | ||
| Q1 25 | $79.0M | $148.4M | ||
| Q4 24 | $76.2M | $120.4M | ||
| Q3 24 | $253.7M | $149.0M | ||
| Q2 24 | $84.5M | $109.7M | ||
| Q1 24 | $118.8M | $61.0M |
| Q4 25 | — | $69.5M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $69.9M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.2B | $409.6M | ||
| Q3 25 | $1.3B | $397.6M | ||
| Q2 25 | $1.4B | $380.0M | ||
| Q1 25 | $1.5B | $372.2M | ||
| Q4 24 | $1.5B | $362.7M | ||
| Q3 24 | $1.6B | $363.5M | ||
| Q2 24 | $660.5M | $350.2M | ||
| Q1 24 | $743.9M | $211.7M |
| Q4 25 | $1.3B | $3.7B | ||
| Q3 25 | $1.4B | $3.6B | ||
| Q2 25 | $1.5B | $3.6B | ||
| Q1 25 | $1.6B | $3.6B | ||
| Q4 24 | $1.7B | $3.5B | ||
| Q3 24 | $1.8B | $3.5B | ||
| Q2 24 | $773.1M | $3.5B | ||
| Q1 24 | $849.7M | $2.4B |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.19× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-96.2M | $46.1M |
| Free Cash FlowOCF − Capex | $-97.3M | $43.6M |
| FCF MarginFCF / Revenue | -487.5% | 113.9% |
| Capex IntensityCapex / Revenue | 5.6% | 6.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-377.3M | $77.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-96.2M | $46.1M | ||
| Q3 25 | $-88.2M | $13.2M | ||
| Q2 25 | $-77.1M | $11.5M | ||
| Q1 25 | $-111.5M | $11.1M | ||
| Q4 24 | $-133.2M | $22.2M | ||
| Q3 24 | $-84.2M | $7.8M | ||
| Q2 24 | $-72.6M | $5.2M | ||
| Q1 24 | $-99.9M | $4.0M |
| Q4 25 | $-97.3M | $43.6M | ||
| Q3 25 | $-89.7M | $12.8M | ||
| Q2 25 | $-78.0M | $10.6M | ||
| Q1 25 | $-112.3M | $10.8M | ||
| Q4 24 | $-134.1M | $17.2M | ||
| Q3 24 | $-84.6M | $5.2M | ||
| Q2 24 | $-72.7M | $4.8M | ||
| Q1 24 | $-100.0M | $3.6M |
| Q4 25 | -487.5% | 113.9% | ||
| Q3 25 | -696.5% | 33.7% | ||
| Q2 25 | -626.2% | 29.6% | ||
| Q1 25 | -1286.4% | 30.9% | ||
| Q4 24 | -1250.1% | 50.0% | ||
| Q3 24 | -944.2% | 16.7% | ||
| Q2 24 | -844.4% | 15.7% | ||
| Q1 24 | -1221.2% | 17.3% |
| Q4 25 | 5.6% | 6.6% | ||
| Q3 25 | 12.1% | 1.1% | ||
| Q2 25 | 7.0% | 2.7% | ||
| Q1 25 | 8.8% | 0.9% | ||
| Q4 24 | 9.0% | 14.7% | ||
| Q3 24 | 4.7% | 8.1% | ||
| Q2 24 | 1.8% | 1.4% | ||
| Q1 24 | 1.7% | 2.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.21× | ||
| Q2 25 | — | 1.47× | ||
| Q1 25 | — | 1.33× | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.09× | 2.29× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
